Table 5.
Summary of available literature
| Study | Patients with lung cancer/Total patients | Patients with native lung cancer | Patients with donor lung cancer | Indication for transplant | Documented pathology |
| Choi et al4 | 1/99 | 1 | N/A | IPF | SCC |
| Spiekerkoetter et al5 | 1/219 | 1 | N/A | N/A | SCC |
| de Perrot et al6 | 1/396 | 1 | N/A | COPD | BAC |
| Stagner et al7 | 2/46 | 2 | N/A | COPD | SCC ×1 Adeno ×1 |
| Schulman et al8 | 2/82 | 1 | N/A | COPD ×2 | SCC ×1 Adeno ×1 |
| Collins et al9 | 3/111 | N/A | N/A | COPD ×2 IPF ×1 |
SCC ×1 NSCLC NOS ×2 |
| Roithmaier et al10 | 5/200 | 4 | N/A | COPD ×4 | NOS* |
| Arcasoy et al11 | 6/251 | 6 | N/A | COPD ×5 IPF ×1 |
SCC ×2 Adeno ×3 Poorly diff ×1 |
| Raviv et al12 | 7/290 | 6 | 1 | COPD ×2 IPF ×4 SSc ×1 |
SCC ×3 Adeno ×3 Poorly diff ×1 |
| Dickson et al13 | 9/131 | 9 | N/A | COPD ×8 IPF ×1 |
SCC ×6 Adeno ×2 Sarcoma ×1 |
| Espinosa et al14 | 9/340 | 8 | N/A | COPD ×5 IPF ×3 CF ×1 |
SCC ×3 Adeno ×3 LCC ×2 SCLC ×1 |
| Gonzalez et al15 | 11/258 | 11 | N/A | COPD ×11 | N/A |
| Minai et al16 | 12/286 | 11 | 1 | COPD ×11 IPF ×1 |
SCC ×3 Adeno ×4 LCC ×3 SCLC ×1 |
| Belli et al17 | 13/335 | 6 | 1 | COPD ×7 IPF ×6 |
SCC ×5 Adeno ×4 Poorly diff ×2 SCLC ×1 Carcinoid ×1 |
| Yserbyt et al18 | 13/494 | 9 | 4 | COPD ×8 PF ×4 GIP ×1 |
SCC ×3 Adeno ×4 LCC ×3 SCLS ×1 NOS ×2 |
| Ekström et al19 | 18/331 | 11 | 7 | COPD ×18 | N/A |
| Pérez-Callejo et al20 | 23/633 | 12 | 6 | COPD ×10 IPF ×11 Primary pulmonary Hemosiderosis ×1 NSIP ×1 |
SCC ×7 Adeno ×13 LCC ×1 SCLC ×1 Poorly diff ×1 |
| Collins et al9 | 24/2168 | 24 | N/A | COPD ×18 IPF ×3 |
SCC ×8 Adeno ×4 Poorly diff ×1 Anaplastic ×1 BAC ×10 |
| This study | 24/905 | 17 | 7 | COPD ×8 IPF ×11 CPFE ×5 |
SCC ×10 Adeno ×8 Other NSCLC ×2 SCLC ×3 |
| Total | 184/7575 | 140 | 27 | COPD ×121 IPF ×43 Others ×20 |
SCC ×47 Adeno ×50 Other NSCLC ×36 SCLC ×8 |
Adeno, adenocarcinoma; BAC, Bronchoalveolar Carcinoma; COPD, chronic obstructive pulmonary disease; CPFE, chronic pulmonary fibrosis with emphysema; diff, differentiated; GIP, giant cell interstitial pneumonia; IPF, idiopathic pulmonary fibrosis; N/A, not available; NOS, not otherwise specified; NSIP, Non-specific Intersitial Pneumonia; PF, Pulmonary Fibrosis; SCC, squamous cell cancer; SCLC, small cell lung cancer; SSc, systemic sclerosis.